It may come down to convincing the judge that it's not reasonable to expect a doctor to follow the narrow generic label of prescribing Vascepa for less than 12 weeks.
Great DD by HGD on the on the "Sanofi v. Glenmark Pharmaceuticals Inc., USA" case. Now I might be able to sleep tonight.
Market Data 
Markets 
AI
